P1530: PERITRANFUSIONAL C1‐INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT‐MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL.
| Autor: | de Boer, E. C. W., Jalink, M., Delvasto‐Nuñes, L., Meulenbroek, E. M., Baas, I., Janssen, S. R., Dijkman, E. E., Gelderman, K. A., Wouters, D., Engel, M. D., de Haas, M., Kersten, M.‐J., Jongerius, I., Zeerleder, S., Vos, J. M. |
|---|---|
| Zdroj: | HemaSphere; 2022 Supplement 3, Vol. 6, p1411-1412, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text